In a federally funded study, researchers from Huntsman Cancer Institute at the University of Utah (the U) found that 7% of Medicare patients cross state borders for cancer care, and rates were nearly ...

The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK said it has given a world-first approval to Rotop's ...

The MHRA has approved the product for three clinical settings, including identifying how far high-risk prostate cancer has ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...